Survey of doctors using Concerto Versa detachable coils to treat blood vessel problems
Collects doctors' reports on how Concerto Versa coils work and how safe they are.
Key facts
- Who runs it
- Medtronic Endovascular
- Where
- El Paso, New York, and Piscataway, United StatesSee the 3 sites
- Trial code
- Registry title
- Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
- Status
- Enrolling by invitation
- People taking part
- 30 people, planned
- Started
- 24 Jul 2026
- Expected to end
- Nov 2026
- Type of study
- Observational
- Treatments tested
- Concerto Versa™ Detachable Coils
- Record updated
- 15 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The survey covers patients treated with a Concerto Versa Detachable Coil, used as the device label says. The case must be reported within 72 hours of the procedure.
- Age
- 22 years or older at the time of the procedure
- Sex
- All sexes
- Earlier treatment
- Treated with a Concerto Versa Detachable Coil as described in the device labeling
Main reasons for not taking part
- Coil not used as the device labeling describes
- Case not reported within 72 hours of the procedure
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patient treated with Concerto Versa™ Detachable Coil is age ≥ 22 years at the time of procedure
- Use of Concerto Versa™ Detachable Coil in accordance with the device labeling
- Reporting of case within 72 hours of index procedure
Where in United States
- Del Sol Medical CenterEl Paso, United StatesEnrolling by invitation
- The Mount Sinai HospitalNew York, United StatesEnrolling by invitation
- Rutgers UniversityPiscataway, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.
The group in the trial
- Adult patients treated with Concerto Versa™ Detachable Coil
The Concerto Versa™ Detachable Coil is indicated for arterial and venous embolization in adult patients requiring embolization in the peripheral vasculature.
Treatment: Concerto Versa™ Detachable Coils
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
- Plain-language title
- Survey of doctors using Concerto Versa detachable coils to treat blood vessel problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 15 October 2026